Lucknow, India

Arwind Kumar Srivastava

This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2005.


% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arwind Kumar Srivastava: Innovator in Cognitive Memory Dysfunction Treatment

Introduction

Arwind Kumar Srivastava is a notable inventor based in Lucknow, India. He has made significant contributions to the field of cognitive health through his innovative research and patents. His work focuses on the treatment of cognitive memory dysfunction, showcasing his commitment to advancing medical science.

Latest Patents

Arwind Kumar Srivastava holds a patent for a method of treating cognitive memory dysfunction using Gugulipid. This invention provides new uses of Gugulipid, an ethyl acetate extract of the resin of the plant, for controlling or preventing cognitive dysfunction, hyperglycemia, and certain infective conditions of the skin. The patent also details a method of preparing Gugulipid by agitating the resin in a shake flask assembly or sonicating assembly, resulting in solid or creamy dosage forms. He has 1 patent to his name.

Career Highlights

Arwind Kumar Srivastava is associated with the Council of Scientific and Industrial Research, where he continues to engage in groundbreaking research. His work has garnered attention for its potential impact on cognitive health and treatment methodologies.

Collaborations

Some of his notable coworkers include Ram Pratap and Raghwendra Pal, who have collaborated with him on various research projects.

Conclusion

Arwind Kumar Srivastava's innovative approach to treating cognitive memory dysfunction highlights the importance of research in improving health outcomes. His contributions to the field are commendable and pave the way for future advancements in cognitive health treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…